Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer.
Linda YeDennis RüngerStephanie A AngaritaJoseph HadayaJennifer L BakerMinna K LeeCarlie K ThompsonDeanna J AttaiMaggie L DiNomePublished in: Breast cancer research and treatment (2022)
Historically, higher risk features have been attributed to patients with clinically positive nodes precluding omission of ALND, but when restricting evaluation to patients with ER + breast cancer, only tumor size is associated with higher nodal stage.